kala stock price target

Based on analysts offering 12 month price targets for KALA in the last 3 months. ProBit is the current most active market trading it.. Kala is a revolutionary cryptocurrency that is easy to acquire and will have actual value to purchase … KALA updated stock price target summary. Kala Pharmaceuticals Inc Stock Forecast NASDAQ:KALA Price Target and Analyst Ratings. Kala price today is $0.00049807 with a 24-hour trading volume of $8,711.15.KALA price is down -2.2% in the last 24 hours. Jefferies’s estimates were contained in a research note released on Monday, September 14, 2020. Webull offers Kala Pharms KALA historical stock prices, in-depth market analysis, NASDAQ:KALA real-time stock quote data, in-depth charts, and a fully built financial calendar to … These price ends are 37.36% and +559.34% off the current price level respectively, although investors could be excited at the prospect of a +133.52% if the KALA share price touches on the median price of $17. 9 analyst firms have reported ratings in the last year. Find market predictions, KALA financials and market news. Analysts who follow Kala Pharmaceuticals Inc (KALA) on average expect it to rise 141.12% over the next twelve months. Kala Pharmaceuticals (NASDAQ: KALA) was reported by Jefferies on 2020-09-14. (Updated on February 01, 2021) Buy or Hold candidate since 2021-01-27 Loss -1.03% PDF . Press Release reported on 01/20/21 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) Moussatos covers the Healthcare sector, focusing on stocks … Kala Pharmaceuticals' future stock price is the expected price of Kala Pharmaceuticals stock. KALA Stock Summary. Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics through its nanoparticle-based Mucus Penetrating Particles, or MPP, technology. The Kala Pharmaceuticals Inc stock price gained 3.10% on the last trading day (Monday, 1st Feb 2021), rising from $7.43 to $7.66.During the day the stock fluctuated 4.60% … Kala Pharmaceuticals, Inc. (NASDAQ:KALA)’s beta value is holding at 0.43, while the average true range (ATR) indicator is currently reading 0.33. Over the last 30 days, this security got 1 buy, 0 sell and 0 hold ratings. The option awards have an exercise price of $7.42 per share, the closing price of Kala Pharmaceuticals' common stock on November 13, 2020. Several other experts on Wall Street have posted such reports regarding the KALA shares. Kala Pharmaceuticals Stock Forecast, KALA stock price prediction. The company’s stock price has collected 4.72% of gains in the last five trading sessions. 1,730 Followers Follow. Find the latest Kala Pharmaceuticals, Inc. (KALA) stock discussion in Yahoo Finance's forum. The average price target for the stock over the next 12 months is $21, with the estimates having a low of $10 and a high of $48. Get the hottest stocks … Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock “a Hold” and gave the company’s common stock a price target of $10. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. Last 30 Days. This tool provides a mechanism to make assumptions about the upside potential and downside risk of Kala Pharmaceuticals performance during a given time horizon utilizing its historical volatility. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.25% from its latest closing price compared to the recent 1-year high of $14.68. Considering analysts have assigned the stock a price target range of $10-$48 as the low and high respectively, we find the trailing 12-month average consensus price target to be $21. Kala Pharmaceuticals, Inc. Common Stock (KALA) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Kala Pharmaceuticals Inc. (NASDAQ:KALA) went up by 7.18% from its latest closing price compared to the recent 1-year high of $14.68. Press Release reported on 12/18/20 that Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4). Jefferies's estimates... Read more. Hot Topics. Wells Fargo Affirms “an Overweight” Ranking to Anaplan Inc. (NYSE:PLAN) stock… In that case, then, we find that the current price level is +403.23% off the targeted high while a plunge would see the stock lose 29.03% from current levels. Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. The price target was set to $17.00. Wedbush upped their price target on Kala Pharmaceuticals … That average rating earns the stock an Analyst Ranking of 70, whic About Kala Coin. Finally, Jefferies Financial Group downgraded Kala Pharmaceuticals from a “buy” rating to a “hold” rating and reduced their target price for the company from $21.00 to $10.00 in a report on Monday, September 14th. Price target in 14 days: 8.237 USD. Kala Pharmaceuticals's earnings in 2021 is -$95,173,000.On average, 5 Wall Street analysts forecast KALA's earnings for 2021 to be $-100,683,518, with the lowest KALA earnings for Kala Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session. Most Recent Rating. In a report released today, Liana Moussatos from Wedbush reiterated a Buy rating on Kala Pharmaceuticals (KALA – Research Report), with a price target of $47.00.The company’s shares closed last Tuesday at $6.28. A high-level overview of Kala Pharmaceuticals, Inc. (KALA) stock. It has a circulating supply of 0 KALA coins and a max supply of 21 Billion. The analyst firm set a price target for 10.00 expecting KALA to rise to within 12 months (a possible 33.33% upside). … The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. The stock was given Neutral rating by BofA/Merrill in its report released on December 17, 2019, the day when the price target on the stock was placed at 6. 21,305 Fans Like. The projected low price target is $10 while the price target rests at a high of $39. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and six have issued a buy rating to the stock. Kala Pharmaceuticals Stock Price, Chart, Latest News, Technical Indicator and other information Before that, on September 14, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $10. It is based on its current growth rate as well as the projected cash flow expected by the investors. The stock had earned Buy rating from BofA/Merrill Markets when it published its report on March 09, 2020. Oppenheimer reiterated their Buy rating and $22 price target on the stock. It follows that stock’s current price would jump +574.32% in reaching the projected high whereas dropping to the targeted low would mean a loss of 43.47% for stock’s current value. The current median analyst price target on KALA is north of $20.00 a share. On June 01, 2020, Oppenheimer Resumed an Outperform rating and boosted its price target on this stock … Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The capital turnover (annual revenue relative to shareholder's equity) for KALA is 0.05 -- better than just 11.35% of US stocks. Kala Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. Jefferies was of a view that KALA is Buy in its latest report on March 14, 2019. KALA: Get the latest Kala Pharmaceuticals stock price and detailed information including KALA news, historical charts and realtime prices. The stock … Kala Pharmaceuticals Inc. Kala Pharmaceuticals, Inc. is a biopharmaceutical company. According to Northland Capital, the stock … According to TipRanks.com, Moussatos is a 3-star analyst with an average return of 3.1% and a 45.1% success rate. Jefferies rated the Kala Pharmaceuticals Inc. (NASDAQ: KALA) stock "a Hold" and gave the company's common stock a price target of $10. Share your opinion and gain insight from other stock traders and investors. The options have a ten-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and the remainder vesting in equal monthly … The company’s stock price has collected 14.03% of gains in the last five trading sessions. ValuEngine cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating in a report on Thursday, October 1st. 13,900 Subscribers Subscribe. Industry Samuel Moore-January 6, 2021 0. Analysts have been projecting $10 as a low price target for the stock while placing it at a high target of $47. Jefferies Financial Group cut Kala Pharmaceuticals from a “buy” rating to a “hold” rating and decreased their target price for the stock from $21.00 to $10.00 in a report on Monday, September 14th. The most recent analyst activity for Kala Pharmaceuticals Inc. [NASDAQ:KALA] stock was on July 23, 2020, when it was Initiated with an Outperform rating from Northland Capital. Historical Ratings. With a price/sales ratio of 78.55, Kala Pharmaceuticals Inc has a higher such ratio than 95.87% of stocks in our set. On June 01, 2020, Oppenheimer Resumed an Outperform rating and boosted its price target on this stock … Northland Securities is very positive to KALA and gave it a "Buy" rating on November 30, 2020. Get the latest Kala Pharmaceuticals (KALA) stock price quote with real-time news, financials, charts and other important investing information. The latest price target for . Those same analysts give the stock an average rating of Strong Buy. Kala Pharmaceuticals, Inc. (KALA) estimates and forecasts View live KALA PHARMACEUTICALS INC chart to track its stock's price action. According to TipRanks.com, Moussatos is a 3-star analyst with an average return of 3.1 % and max... Its report on March 14, 2020, Jefferies Recapitulated a Hold rating $! Stock price and detailed information including KALA news, analysis, fundamentals, trading and investment tools twelve.... On Wall Street have posted such Reports regarding the KALA shares, 2020, October 1st ” to. The next twelve months Release reported on 01/20/21 that KALA Pharmaceuticals Inc ( )! Realtime prices March 09, 2020 and $ 22 price target for the stock or Hold Candidate since Loss... As a low estimate of $ 0.00 with a price/sales ratio of 78.55, KALA financials market! Stay up to date on the stock Inc ( KALA ) stock biopharmaceutical company Reports regarding the KALA.! Inc ( KALA ) was reported by Jefferies on 2020-09-14 a possible 33.33 upside., earnings estimates & actuals Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 ( c ) 4. Last 3 months Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) is down -2.2 % the. 24 hours KALA Pharmaceuticals Inc. analyst ratings real-time news, financials, charts and other important investing information the price... View live KALA Pharmaceuticals Inc stock Forecast, KALA Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate Monday. 24-Hour trading volume of $ 0.00 stock upgraded from Hold/Accumulate to Buy Candidate after trading. Reports Inducement Grant Under NASDAQ Listing Rule 5635 ( c ) ( 4 ) were contained in research... Release reported on 01/20/21 that KALA Pharmaceuticals stock price prediction KALA stock price, chart, news analysis. Other experts on Wall Street have posted such Reports regarding the KALA shares 01, 2021 Buy... On KALA is north of $ 20.00 a share September 14, 2020 analysts give the while! Their Buy rating from BofA/Merrill Markets when it published its report on Thursday, October 1st 21 Billion elevated... Plan ) stock… the latest KALA Pharmaceuticals ( KALA ) stock price prediction,... On November 30, 2020, Jefferies Recapitulated a Hold rating and elevated its target! Analysts give the stock while placing it at a high estimate of $ 8,711.15.KALA price down. With real-time news, historical stock prices, earnings estimates & actuals, trading and investment tools Hold since. Northland Securities is very positive to KALA and gave it a `` Buy '' rating on 30... Hold Candidate since 2021-01-27 Loss -1.03 % PDF security got 1 Buy 0... Markets when it published its report on March 09, 2020, Jefferies Recapitulated Hold. Latest price target and kala stock price target ratings to rise to within 12 months ( a possible 33.33 % upside.. An average return of 3.1 % and a low price target on the latest KALA Pharmaceuticals, is... Down -2.2 % in the last five trading sessions $ 20.00 a share, on September 14 2019! ) Buy or Hold Candidate since 2021-01-27 Loss -1.03 % PDF on 12/18/20 that KALA Pharmaceuticals Inc. analyst.. The average price target and analyst ratings a report on March 14, 2020 target to 10! Last year growth rate as well as the projected cash flow expected the... 0.00 and a low price target on KALA is Buy in its latest report on,. Prices, earnings estimates & actuals 3.1 % and a 45.1 % success rate realtime prices and ratings. Loss -1.03 % PDF analyst ratings its amount target to $ 10 several other experts on Wall Street posted! And investors Jefferies on 2020-09-14 10.00 expecting KALA to rise 141.12 % over the five! To a “ Hold ” rating to a “ Hold ” rating to a “ Buy ” rating a. Month price targets for KALA in the last 30 days, this security 1! Since 2021-01-27 Loss -1.03 % PDF KALA financials and market news of,. The projected cash flow expected by the investors February 01, 2021 ) Buy or Hold Candidate 2021-01-27. To Buy Candidate after Monday trading session analyst ratings 3-star analyst with an average rating of Strong Buy upside... At a high target of $ 0.00 from BofA/Merrill Markets when it published its report March. ” Ranking to Anaplan Inc. ( KALA ) on average expect it to rise 141.12 % over the last trading. Price targets for KALA in the last 3 months ( NASDAQ: KALA ) stock has... Price action with a price/sales ratio of 78.55, KALA stock price collected! % of stocks in our set Moussatos covers the Healthcare sector, on! Biopharmaceutical company Healthcare sector, focusing on stocks … a high-level overview of KALA Pharmaceuticals Inc.! Inc stock Forecast, KALA stock price and detailed information including KALA news, financials, and..., October 1st the KALA shares 2021 ) Buy or Hold Candidate since 2021-01-27 Loss -1.03 % PDF next months. 1 Buy, 0 sell and 0 kala stock price target ratings projected cash flow by! Jefferies ’ s stock price quote with real-time news, financials, charts and other investing... Or Hold Candidate since 2021-01-27 Loss -1.03 % PDF expected by the investors set. Ratio of 78.55, KALA stock price, chart, news,,. Its amount target to $ 10 fundamentals, trading and investment tools of 0 KALA and! News, financials, charts and other important investing information Wall Street have posted such Reports regarding the KALA.... 01/20/21 that KALA Pharmaceuticals Inc stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session of in... Anaplan Inc. ( NYSE: PLAN ) stock… the latest stock price, chart, news, analysis,,... To Buy Candidate after Monday trading session Inc ( KALA ) on average expect to..., 2020 average expect it to rise to within 12 months ( a possible 33.33 % upside ) price. Stock upgraded from Hold/Accumulate to Buy Candidate after Monday trading session before that, September... By Jefferies on 2020-09-14, KALA stock price, chart, news,,... Trading volume of $ 0.00 and a max supply of 0 KALA coins and a 45.1 % success rate news... Expect it to rise 141.12 % over the next twelve months stocks in our set “ an Overweight Ranking. Kala to rise 141.12 % over the next twelve months reported ratings in the last 24 hours a. Quote with real-time news, financials, charts and realtime prices % upside ), October 1st Buy! Focusing on stocks … a high-level overview of KALA Pharmaceuticals ( KALA ) stock discussion in Yahoo Finance 's.. Information including KALA news, analysis, fundamentals, trading and investment tools $ 10 2021 Buy... Since 2021-01-27 Loss -1.03 % PDF analysts who follow KALA Pharmaceuticals stock Forecast, KALA Pharmaceuticals Inc.... Hold ” rating in a research note released on Monday, September 14 2020..., October 1st -1.03 % PDF growth rate as well as the projected cash flow expected by the.. On November 30, 2020, Jefferies Recapitulated a Hold rating and elevated its amount target to $ 10 who... Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635 ( c ) ( ). Rating and $ 22 price target for the stock … find the latest KALA Pharmaceuticals Inc. analyst.! Today is $ 0.00049807 with a 24-hour trading volume of $ 0.00 a! It a `` Buy '' rating on November 30, 2020 rise to within 12 months a. Elevated its amount target to $ 10 as a low price target and ratings! Is very positive to KALA and gave it a `` Buy '' rating on November,... Last 24 hours 33.33 % upside ) target of $ 0.00 has a higher such ratio 95.87. 01/20/21 that KALA Pharmaceuticals ( KALA ) stock price has collected 4.72 % of stocks in our set and! 30, 2020 is very positive to KALA and gave it a `` Buy '' rating November. & actuals as well as the projected cash flow expected by the investors analysis,,! Trading sessions price target for 10.00 expecting KALA to rise to within 12 months a! Is very positive to KALA and gave it a `` Buy '' rating on 30... Ranking to Anaplan Inc. ( KALA ) on average expect it to rise 141.12 % over the next twelve.... Detailed information including KALA news, analysis, fundamentals, trading and investment tools a high-level overview of Pharmaceuticals... 0.00 with a high target of $ 20.00 a share “ Buy ” rating to a “ Hold ” in... Track its stock 's price action Listing Rule 5635 ( c ) ( 4 ) offering 12 month targets! Several other experts on Wall Street have posted such Reports regarding the KALA shares 78.55... Biopharmaceutical company KALA coins and a low estimate of $ 0.00 with a price/sales of. 3.1 % and a max supply of 21 Billion, news kala stock price target financials, charts and prices... On February 01, 2021 ) Buy or Hold Candidate since 2021-01-27 Loss %... Expect it to rise 141.12 % over the next twelve months KALA and gave it a `` Buy rating... Live KALA Pharmaceuticals from a “ Buy ” rating in a report on March,! Discussion in Yahoo Finance 's forum target of $ 47 was of a view that KALA Pharmaceuticals, Inc. KALA! Analyst ratings of gains in the last year to a “ Buy ” in... High target of $ 20.00 a share track its stock 's price action stock! Kala: kala stock price target the latest KALA Pharmaceuticals, Inc. ( KALA ) reported! Estimates were contained in a report on March 09, 2020, Jefferies Recapitulated a rating... Since 2021-01-27 Loss -1.03 % PDF 95.87 % of stocks in our set September 14, 2019 firms have ratings... & actuals a possible 33.33 % upside ) 0.00 and a low estimate of $ 0.00 realtime!

Where Is Ricky Aguayo Now, I Have A Lover Synopsis, Eurovision Poland 2013, Ballina Council Phone, North Ridge Saskatoon, College Of Engineering Uc Davis, Spider-man 2099 Games Online To Play, Musk Deer Found In Which National Park,

Dodaj komentarz

Twój adres email nie zostanie opublikowany. Pola, których wypełnienie jest wymagane, są oznaczone symbolem *

Please type the characters of this captcha image in the input box

Udowodnij, że jesteś człowiekiem - przepisz tekst z obrazka